학술논문
Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study
Document Type
Article
Author
Source
In European Journal of Surgical Oncology 2009 35(10):1048-1054
Subject
Language
ISSN
0748-7983